Event Type
Disclosure
Mandatory
Variant
8-K
Entry into a Material Definitive Agreement. Private Placement and Securities Purchase Agreement On July 21, 2025, DiaMedica Therapeutics Inc., a corporation exi
. Based in part on the representations of the Purchasers in the Securities Purchase Agreement, the offering and sale of the Shares will be exempt from registrat
Other Events. On July 21, 2025, the Company issued a press release announcing the Private Placement and the entry into the Securities Purchase Agreement, which
. Financial Statements and Exhibits. (d) Exhibits. The following exhibit is filed herewith: Exhibit Number Description 10.1 Form of Securities Purchase Agreemen